Purified anti-mouse CD8a (Maxpar® Ready) 100755 from BioLegend

Product Specs
ItemPurified anti-mouse CD8a (Maxpar® Ready)
CompanyBioLegend
Price $83.00Supplier Page View Company Product Page
Catalog Number100755
Quantity100 µg
ApplicationsFC - Quality tested, CyTOF®, - Verified
Concentration1.0mg/ml
Conjugate/TagUnconjugated
FormatPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA
ReactivityMouse
IsotypeRat IgG2a, kappa
Clone53-6.7
HostRat
Antibody TypePrimary
ImmunogenMouse thymus or spleen
NCBI Full Gene NameCD8 subunit alpha
NCBI Gene AliasesLy-2, Ly-35, Ly-B, Lyt-2
ClonalityMonoclonal
TargetCD8alpha

Add to Compare List

BioLegend

8999 BioLegend Way

San Diego, California 92121

United States

Phone: 1-877-246-5343 Toll-Free, USA & Canada
1-858-768-5800 International
Fax: 1-877-455-9587

Company Profile

Website: biolegend.com

(1) Innate type 2 immunity controls hair follicle commensalism by Demodex mitesImmunityOctober 11, 2022Ricardo-Gonzalez RR, Kotas ME, O'Leary CE, Singh K, Damsky W, Liao C, Arouge E, Tenvooren I, Marquez DM, Schroeder AW, et al.,BD Biosciences,Cat#612288; RRID:AB_399605 Purified anti-mouse CD8a (Maxpar® Ready) Antibody,BioLegend,Cat#100755; RRID:AB_2562796 Purified anti-mouse CD4 (Maxpar® Ready) Antibody,BioLegend,Cat#100561; RRID:AB_2562762 BD

(2) Dietary Intake Regulates the Circulating Inflammatory Monocyte PoolCellAugust 22, 2019Jordan S, Tung N, Casanova-Acebes M, Chang C, Cantoni C, Zhang D, Wirtz TH, Naik S, Rose SA, Brocker CN, et al.

(3) Jak1 Integrates Cytokine Sensing to Regulate Hematopoietic Stem Cell Function and Stress HematopoiesisCell stem cellOctober 5, 2017Kleppe M, Spitzer MH, Li S, Hill CE, Dong L, Papalexi E, De Groote S, Bowman RL, Keller M, Koppikar P, et al.,BD Biosciences,552125 PDCA-1,Imgenex,MAB8660 Ly6C,Biolegend,128039 CD48,Biolegend,103433 CD11b,Biolegend,101249 cKit,Biolegend,105829 CD8,Biolegend,100755 CD4,Biolegend,100561 CD3,BD Biosciences,555273 TCRb,Biolegend,109235 B220,BD Biosciences,103249 NK1.1,Biolegend,108743 CD127,Biolegend,121102 CD105,Biolegend,120401 Sca-1,Biolegend,108135 CD150,eBiosciences,14-1501-82 FcER1a,Biolegend,134321 CD135,eBiosciences,14-1351-82 CD25,Biolegend,101902 F4/80,Biolegend,123143 CD115,Biolegend,135521 CD71,Biolegend,113802 CD23,Biolegend,101625 CD19,Biolegend,115547 IgM,Biolegend,406527 CD44,BD Biosciences

(4) Flt3L-mobilized dendritic cells bearing H2-Kbm1 apoptotic cells do not induce cross-tolerance to CD8+ T cells across a class I MHC mismatched barrierTransplant international : official journal of the European Society for Organ TransplantationMay 1, 2011Maria-Luisa del Rio, Javier Cote-Sierra, Jose-Ignacio Rodriguez-Barbosa

(5) IFN-gamma inhibits IL-4-induced type 2 cytokine expression by CD8 T cells in vivo and modulates the anti-tumor responseJournal of immunology (Baltimore, Md. : 1950)July 15, 2010Apte SH, Groves P, Olver S, Baz A, Doolan DL, Kelso A, Kienzle N.

(6) Effects of TCDD on the fate of naive dendritic cellsToxicological sciences : an official journal of the Society of ToxicologyJune 1, 2010Bankoti J, Burnett A, Navarro S, Miller AK, Rase B, Shepherd DM.

(7) Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF lossBloodFebruary 11, 2010Medyouf H, Gao X, Armstrong F, Gusscott S, Liu Q, Gedman AL, Matherly LH, Schultz KR, Pflumio F, You MJ, et al.

(8) XBP1 governs late events in plasma cell differentiation and is not required for antigen-specific memory B cell developmentThe Journal of experimental medicineSeptember 28, 2009Todd DJ, McHeyzer-Williams LJ, Kowal C, Lee AH, Volpe BT, Diamond B, McHeyzer-Williams MG, Glimcher LH.

(9) Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potentialJournal of immunology (Baltimore, Md. : 1950)July 1, 2009Riedl P, Wieland A, Lamberth K, Buus S, Lemonnier F, Reifenberg K, Reimann J, Schirmbeck R.

(10) Tumor-localized ligation of CD3 and CD28 with systemic regulatory T-cell depletion induces potent innate and adaptive antitumor responsesClinical cancer research : an official journal of the American Association for Cancer ResearchApril 15, 2009Lee CH, Chiang YH, Chang SE, Chong CL, Cheng BM, Roffler SR.

(11) Core binding factors are necessary for natural killer cell development and cooperate with Notch signaling during T-cell specificationBloodAugust 1, 2008Guo Y, Maillard I, Chakraborti S, Rothenberg EV, Speck NA.

(12) The absence of Toll-like receptor 4 signaling in C3H/HeJ mice predisposes them to overwhelming rickettsial infection and decreased protective Th1 responsesInfection and immunityAugust 1, 2008Jordan JM, Woods ME, Olano J, Walker DH.

(13) The early kinetics of cytomegalovirus-specific CD8+ T-cell responses are not affected by antigen load or the absence of perforin or gamma interferonJournal of virologyMay 1, 2008Andrews DM, Andoniou CE, Fleming P, Smyth MJ, Degli-Esposti MA.

(14) Loss of CD8 and TCR binding to Class I MHC ligands following T cell activationInternational immunologyDecember 1, 2005Kao C, Daniels MA, Jameson SC.

(15) alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumorJournal of immunology (Baltimore, Md. : 1950)September 1, 2005Ko SY, Ko HJ, Chang WS, Park SH, Kweon MN, Kang CY.

Be the First to Write a Review!

Purified anti-mouse CD8a (Maxpar® Ready) from BioLegend

Description

BioLegend

Citations (15)

Reviews

Purified anti-mouse CD8a (Maxpar® Ready) from BioLegend

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map